Keywords: Fosun Pharma, Aleph Biomed, M&A, Flue vaccine

China’s Fosun buys 75% stake in Aleph Biomed for $102 million

Article | 15 February 2011

Print This

With the aim of expanding its production portfolio and competitive position, Chinese drugmaker Fosun Pharmaceutical has bought a 75% stake in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in